Urea Cycle Disorder Treatment Market
According to Intent Market Research, the Urea Cycle Disorder Treatment Market is expected to grow from USD 452.7 million in 2024-e at a CAGR of 13.8% to touch USD 983.3 million by 2030. The Urea Cycle Disorder Treatment Market is dominated by key players such as, Nutricia North America, American Gene Technologies, Alexion Pharmaceuticals, Synthego Corporation, and Shire Pharmaceuticals.